GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 141 filers reported holding GERON CORP in Q3 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $611 | -33.9% | 288 | 0.0% | 0.00% | – |
| Q2 2023 | $924 | +47.8% | 288 | 0.0% | 0.00% | – |
| Q1 2023 | $625 | -10.3% | 288 | 0.0% | 0.00% | – |
| Q4 2022 | $697 | -30.3% | 288 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | – | 288 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q1 2021 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q4 2020 | $0 | -100.0% | 288 | 0.0% | 0.00% | – |
| Q3 2020 | $1,000 | 0.0% | 288 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 288 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q2 2019 | $0 | – | 288 | 0.0% | 0.00% | – |
| Q1 2019 | $0 | – | 288 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |